MK13_HUMAN - dbPTM
MK13_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MK13_HUMAN
UniProt AC O15264
Protein Name Mitogen-activated protein kinase 13
Gene Name MAPK13
Organism Homo sapiens (Human).
Sequence Length 365
Subcellular Localization
Protein Description Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK13 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors such as ELK1 and ATF2. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. MAPK13 is one of the less studied p38 MAPK isoforms. Some of the targets are downstream kinases such as MAPKAPK2, which are activated through phosphorylation and further phosphorylate additional targets. Plays a role in the regulation of protein translation by phosphorylating and inactivating EEF2K. Involved in cytoskeletal remodeling through phosphorylation of MAPT and STMN1. Mediates UV irradiation induced up-regulation of the gene expression of CXCL14. Plays an important role in the regulation of epidermal keratinocyte differentiation, apoptosis and skin tumor development. Phosphorylates the transcriptional activator MYB in response to stress which leads to rapid MYB degradation via a proteasome-dependent pathway. MAPK13 also phosphorylates and down-regulates PRKD1 during regulation of insulin secretion in pancreatic beta cells..
Protein Sequence MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSPIARKDSRRRSGMKL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSLIRKKGF
------CCCHHCCCC
32.2924719451
10PhosphorylationLIRKKGFYKQDVNKT
CHHCCCCCCCCCCCC
19.19-
24PhosphorylationTAWELPKTYVSPTHV
CHHHCCCCEECCCCC
27.5023312004
25PhosphorylationAWELPKTYVSPTHVG
HHHCCCCEECCCCCC
12.6923312004
27PhosphorylationELPKTYVSPTHVGSG
HCCCCEECCCCCCCC
17.4224719451
29PhosphorylationPKTYVSPTHVGSGAY
CCCEECCCCCCCCCC
22.9928348404
33PhosphorylationVSPTHVGSGAYGSVC
ECCCCCCCCCCHHHH
21.1123312004
36PhosphorylationTHVGSGAYGSVCSAI
CCCCCCCCHHHHHHH
17.2923312004
38PhosphorylationVGSGAYGSVCSAIDK
CCCCCCHHHHHHHHC
13.7923312004
47PhosphorylationCSAIDKRSGEKVAIK
HHHHHCCCCCEEEEE
57.9822817900
123PhosphorylationKIMGMEFSEEKIQYL
HHHCCCCCHHHHHHH
31.3829116813
129PhosphorylationFSEEKIQYLVYQMLK
CCHHHHHHHHHHHHH
11.1229116813
143PhosphorylationKGLKYIHSAGVVHRD
HCCCHHHHCCEECCC
19.70-
180PhosphorylationRHADAEMTGYVVTRW
HHCCHHHCCEEEEEE
19.5027273156
182PhosphorylationADAEMTGYVVTRWYR
CCHHHCCEEEEEEEE
5.2027273156
185PhosphorylationEMTGYVVTRWYRAPE
HHCCEEEEEEEECCH
12.8723927012
226UbiquitinationGKTLFKGKDYLDQLT
CCCCCCCHHHHHHHH
43.7321906983
261PhosphorylationAAKSYIQSLPQTPRK
HHHHHHHCCCCCCCC
32.2427251275
265PhosphorylationYIQSLPQTPRKDFTQ
HHHCCCCCCCCCHHH
24.1129496963
350PhosphorylationYKEIVNFSPIARKDS
HHHHHCCCCCCCCHH
15.3622617229
357PhosphorylationSPIARKDSRRRSGMK
CCCCCCHHCHHCCCC
30.62-
361PhosphorylationRKDSRRRSGMKL---
CCHHCHHCCCCC---
41.23-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
180TPhosphorylationKinaseMKK3P46734
PSP
180TPhosphorylationKinaseMAP2K4P45985
Uniprot
180TPhosphorylationKinaseMKK6P52564
PSP
180TPhosphorylationKinaseMAP2K7O14733
Uniprot
182YPhosphorylationKinaseMKK3P46734
PSP
182YPhosphorylationKinaseMAP2K4P45985
Uniprot
182YPhosphorylationKinaseMKK6P52564
PSP
182YPhosphorylationKinaseMAP2K7O14733
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
180TPhosphorylation

9374491

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MK13_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ATF2_HUMANATF2physical
12244047
FGF12_HUMANFGF12physical
12244047
AKIP1_HUMANAKIP1physical
18624398
ANKL2_HUMANANKLE2physical
18624398
MBP_HUMANMBPphysical
17906618
HTRA2_HUMANHTRA2physical
17906618
A4_HUMANAPPphysical
21832049
TAU_HUMANMAPTphysical
9199504
POTEF_HUMANPOTEFphysical
26186194
M3K4_HUMANMAP3K4physical
25241761
MAPK3_HUMANMAPKAPK3physical
25241761
SQSTM_HUMANSQSTM1physical
26279575
POTEF_HUMANPOTEFphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MK13_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND MASSSPECTROMETRY.
"Characterization of the structure and function of the fourth memberof p38 group mitogen-activated protein kinases, p38delta.";
Jiang Y., Gram H., Zhao M., New L., Gu J., Feng L., Di Padova F.,Ulevitch R.J., Han J.;
J. Biol. Chem. 272:30122-30128(1997).
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-180 AND TYR-182,MUTAGENESIS OF THR-180 AND TYR-182, ENZYME REGULATION, AND TISSUESPECIFICITY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-182, AND MASSSPECTROMETRY.

TOP